Improving the quality of life in Arizona to benefit future generations.
Molecular Profiling Institute, the first spinoff of Phoenix's International Genomics Consortium and the Translational Genomics Research Institute, has been acquired for approximately $40 million by Caris Diagnostics, a Texas biotech firm, signaling the potential for Arizona's investment in the biosciences to yield significant returns.